Who owns NEUROGENE INC?
- Ticker: NGNE
- CUSIP Number: 64135m105
Tip: Access positions for across all investors
Analyze quarterly positions in Neurogene with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurogene stock
Who bought or sold NEUROGENE INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EcoR1 Capital | 1.3M | $65M | 0% | Mar 2024 |
|
| Samsara BioCapital | 1.3M | $65M | 0% | Mar 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.0M | $51M | 1% | Mar 2024 |
|
| Redmile Group | 935k | $48M | -1% | Mar 2024 |
|
| BlackRock | 855k | $44M | 100% | Mar 2024 |
|
| Henderson Group | 813k | $41M | -3% | Mar 2024 |
|
| Cormorant Asset Management | 539k | $27M | -28% | Mar 2024 |
|
| Casdin Capital | 525k | $27M | 0% | Mar 2024 |
|
| Morgan Stanley | 517k | $26M | 100% | Mar 2024 |
|
| Vanguard Group | 508k | $26M | 906% | Mar 2024 |
|
| Avidity Partners Management | 465k | $24M | 0% | Mar 2024 |
|
| Baker Bros. Advisors | 456k | $23M | 1% | Mar 2024 |
|
| Arrowpoint Asset Management | 438k | $22M | -17% | Mar 2024 |
|
| Commodore Capital | 200k | $10M | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 172k | $8.7M | 100% | Mar 2024 |
|
| Susquehanna International | 131k | $6.7M | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 101k | $5.1M | -46% | Mar 2024 |
|
| Altium Capital Management | 100k | $5.1M | 100% | Mar 2024 |
|
| Geode Capital Management | 99k | $5.1M | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 87k | $4.4M | 100% | Mar 2024 |
|
| Millennium Management | 83k | $4.2M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 74k | $3.8M | 100% | Mar 2024 |
|
| Qube Research & Technologies | 73k | $3.7M | 100% | Mar 2024 |
|
| Nantahala Capital Management | 72k | $3.7M | 0% | Mar 2024 |
|
| Jane Street | 55k | $2.8M | 100% | Mar 2024 |
|
| Marshall Wace | 30k | $1.5M | 100% | Mar 2024 |
|
| Point72 Asset Management | 28k | $1.4M | 100% | Mar 2024 |
|
| Northern Trust | 23k | $1.2M | 100% | Mar 2024 |
|
| Bank of America Corporation | 21k | $1.0M | -59% | Mar 2024 |
|
| Bessemer | 20k | $388k | 100% | Dec 2023 |
|
| Citigroup | 18k | $892k | 100% | Mar 2024 |
|
| Eudaimonia Asset Management | 12k | $616k | 100% | Mar 2024 |
|
| Marathon Trading Investment Management | 12k | $611k | 100% | Mar 2024 |
|
| Barclays | 12k | $611k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 11k | $546k | 100% | Mar 2024 |
|
| Stifel Financial | 9.8k | $498k | 100% | Mar 2024 |
|
| UBS Group | 9.7k | $495k | 872% | Mar 2024 |
|
| Brevan Howard Capital Management | 8.1k | $411k | 100% | Mar 2024 |
|
| American Century Companies | 6.7k | $343k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 6.4k | $325k | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 5.9k | $301k | 100% | Mar 2024 |
|
| Privium Fund Management | 5.9k | $274k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 5.2k | $267k | 100% | Mar 2024 |
|
| Point72 Asia | 5.0k | $255k | 100% | Mar 2024 |
|
| Two Sigma Investments | 4.0k | $202k | 100% | Mar 2024 |
|
| SG Americas Securities | 2.3k | $120k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 661.00 | $34k | -88% | Mar 2024 |
|
| Wells Fargo & Company | 471.00 | $24k | 14% | Mar 2024 |
|
| Farther Finance Advisors | 50.00 | $2.3k | 0% | Mar 2024 |
|
| Huntington National Bank | 10.00 | $509.000000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 10.00 | $509.000000 | 0% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 8.00 | $158.000000 | 100% | Dec 2023 |
|
| Northwestern Mutual Wealth Management Company | 5.00 | $255.000000 | 100% | Mar 2024 |
|
Who sold out of Neurogene?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BML Capital Management | Dec 2023 | 25k | $478k |
| Us Bancorp | Dec 2023 | 3.5k | $67k |
| Royal Bank of Canada | Dec 2023 | 104.00 | $2.0k |
| Advisor Group Holdings | Dec 2023 | 25.00 | $485.000000 |